Psychedelic substances like psilocybin (found in magic mushrooms), MDMA (commonly known as ecstasy), LSD (commonly known as acid), and ayahuasca have shown potential in treating conditions such as depression, post-traumatic stress disorder (PTSD), and addiction. These substances can induce profound psychological experiences that, when paired with psychotherapy — a form of talk therapy — have been proposed to lead to significant therapeutic benefits.

The patient has multiple myeloma, one of the most common haematological (blood) cancers worldwide.

In patients under the age of 70, the first-line treatment for this cancer includes harvesting the patient's own cells, known as “haematopoietic progenitor cells”, intensive chemotherapy and, finally, reinfusion of the previously harvested cells. These haematopoietic progenitor cells are capable of giving rise to all types of blood cells normally produced by the bone marrow.

Additionally, we will explore the ongoing evolution of minimally invasive techniques and their impact on the patient's quality of life, even on complex cases, such as lateral compartment resections in rectal cancer and D3 lymphadenectomy in colon cancer.

“Surgery can cure”, said Markus Büchler, director of the newly opened Botton-Champalimaud Pancreatic Cancer Centre, in Lisbon, during his talk. Büchler was referring to a form of pancreatic cancer surgery called the “triangle operation”, which he invented and developed.

The Champalimaud Foundation's Breast Cancer Research Programme is made up of groups dedicated to all aspects related to the disease, from diagnosis to treatment. The goal is to improve the quality of life and survival of patients by utilising cutting-edge technologies that combine new techniques and methods with clinical practice to better serve patients.

With nearly 30 presenters—including 4 keynote speakers—ranging from internationally renowned scientists to emerging researchers, the symposium was structured into eight thematic sessions, each exploring different dimensions, from the interplay between tumour cells and their microenvironment to the systemic impacts of cancer on the body.

“I’m exactly as I was 10 years ago”, says Kina García, a Spanish woman from the Granada region, as she addresses by Zoom, from her home, the audience of the International Conference on Neurodegenerative Diseases, gathered on a Saturday morning at the Champalimaud Foundation’s auditorium, in Lisbon. The date is appropriate: it is September 21 – World Alzheimer's Day. 

This 2-day conference organised by the Champalimaud Foundation, in partnership with Faculdade de Motricidade Humana, will provide an overview of the scientific landscape in the area of physical activity and cancer, from prevention to rehabilitation and survivorship.

These are exciting times for research in this space as physical activity becomes more widely recognised as a powerful partner in the prevention and treatment of cancer.

On the 3rd of October, a full day pre-meeting summit was held on the KPro, the revolutionising keratoprosthesis developed by Claes Dohlman, laureate of the 2022 António Champalimaud Vision Award, receiving it shortly after his 100th birthday. The summit celebrated Dohlman’s legacy with recent advances partly funded by the award and innovative work from around the globe.